Obama Wants His Private Presidential Center on Public Land—and Mainstream Media Is Looking the Other Way
Obama gets yet another undeserved free pass, this time over his Presidential library.
Read more...Obama gets yet another undeserved free pass, this time over his Presidential library.
Read more...The Pfizer consent form for a clinical of its booster shot is troubling from a participants and public health persepctive.
Read more...Feminists failed to press for abortion laws when they had political winds at their backs. Women in Flyover are already paying for this lapse.
Read more...A prominent example of Serious People giving lip service to the disastrous consequences of climate change, with no urgent call to action.
Read more...Bullet points and tables can’t compensate for years of disinvestment.
Read more...Pfizer wants to legalize kickbacks.
Read more...Bob Smith got the Watergate break-in leak before the Washington Post. But the New York Times, then as now, avoids tough political stories.
Read more...Industrial policy is an idea whose time has arrived in DC. Too bad the thinking seems stuck in the fad-chashing phase.
Read more...More voters recognize that the Democrats will do squat about expanded health coverage like Medicare for All unless they feel some heat
Read more...Cuomo, like his Team Dem allies, insists the vaccines will allow him to stay the reopening course when Delta is throwing a big money wrench
Read more...The New York Times is impartial when convenient…which wasn’t during Watergate, My Lai, the Iraq War, and the Trump era, for instance
Read more...If you weren’t worried about Covid, you should be, between rising infections and evidence of CDC incompetence.
Read more...Biogen plans to price-gouge for the barely-effective Alzheimer’s drug aducanumab to such a degree that it could bust Medicare.
Read more...Trying to understand America’s self-and-other-destructive empire fetish.
Read more...The Biden administration should push the WTO to waive COVID vaccine patents before heading off for vacation and encourage U.S. producers to ramp up low-cost vaccine production worldwide.
Read more...